Trade Generation Bio Co. - GBIO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.04 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.4 |
| Open | 0.39 |
| 1-Year Change | -85.97% |
| Day's Range | 0.39 - 0.41 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 0.40 | 0.00 | 0.00% | 0.40 | 0.41 | 0.40 |
| Apr 23, 2025 | 0.43 | 0.04 | 10.26% | 0.39 | 0.43 | 0.39 |
| Apr 22, 2025 | 0.38 | -0.02 | -5.00% | 0.40 | 0.40 | 0.38 |
| Apr 21, 2025 | 0.40 | 0.01 | 2.56% | 0.39 | 0.44 | 0.39 |
| Apr 17, 2025 | 0.33 | 0.00 | 0.00% | 0.33 | 0.33 | 0.33 |
| Apr 16, 2025 | 0.34 | -0.01 | -2.86% | 0.35 | 0.35 | 0.34 |
| Apr 15, 2025 | 0.35 | -0.01 | -2.78% | 0.36 | 0.36 | 0.35 |
| Apr 14, 2025 | 0.37 | 0.00 | 0.00% | 0.37 | 0.37 | 0.37 |
| Apr 3, 2025 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
| Apr 1, 2025 | 0.38 | -0.02 | -5.00% | 0.40 | 0.40 | 0.38 |
| Mar 31, 2025 | 0.39 | -0.02 | -4.88% | 0.41 | 0.41 | 0.39 |
| Mar 28, 2025 | 0.41 | -0.02 | -4.65% | 0.43 | 0.43 | 0.40 |
| Mar 27, 2025 | 0.42 | -0.02 | -4.55% | 0.44 | 0.47 | 0.42 |
| Mar 26, 2025 | 0.43 | -0.03 | -6.52% | 0.46 | 0.47 | 0.43 |
| Mar 25, 2025 | 0.45 | -0.02 | -4.26% | 0.47 | 0.47 | 0.44 |
| Mar 24, 2025 | 0.47 | -0.01 | -2.08% | 0.48 | 0.52 | 0.46 |
| Mar 21, 2025 | 0.48 | 0.00 | 0.00% | 0.48 | 0.48 | 0.45 |
| Mar 20, 2025 | 0.49 | -0.02 | -3.92% | 0.51 | 0.52 | 0.49 |
| Mar 19, 2025 | 0.52 | -0.04 | -7.14% | 0.56 | 0.56 | 0.50 |
| Mar 18, 2025 | 0.54 | 0.02 | 3.85% | 0.52 | 0.57 | 0.50 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Generation Bio Co. Company profile
About Generation Bio Co
Generation Bio Co. is genetic medicines to provide treatments of rare and prevalent diseases. The Company through its non-viral genetic medicine platform, is engaged in developing genetic medicines to provide genetic payloads, which include large and multiple genes to a range of cell types across a range of diseases. It is comprised of three component technologies: ceDNA, ctLNP and ceDNA manufacturing process. ceDNA is an engineered, double-stranded, linear, covalently closed-ended deoxyribonucleic acid (DNA) construct, which includes the gene of interest and associated regulatory sequences. It has produced ceDNA constructs of approximately eight kilobases. Its ctLNP delivery system builds upon clinically validated lipid nanoparticles and is designed to allow for repeat dosing of a genetic payload without stimulating an immune response, such as antibody production. Its ceDNA manufacturing process uses its own cell-free rapid enzymatic synthesis (RES) to produce ceDNA.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Generation Bio Co revenues was not reported. Net loss increased 48% to $119.2M. Higher net loss reflects alancing val increase of 39% to $51M (expense), Labor & Related Expenses in R&D increase of 43% to $24.9M (expense), Stock-based Compensation in R&D increase from $4.3M to $9.3M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.74 to -$2.12.
| Industry: | Bio Therapeutic Drugs |
301 Binney Street
CAMBRIDGE
MASSACHUSETTS 02142
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com